drug-eluting balloons

Tips and Techniques
The Evolving Field of Local Drug Delivery for Superficial Femoral Artery Intervention
05/05/2017
Local drug delivery is rapidly emerging as the first line of therapy for the interventional treatment of superficial femoral artery disease. Paclitaxel-eluting drug-coated balloons are emerging as a promising therapy.
Local drug delivery is rapidly emerging as the first line of therapy for the interventional treatment of superficial femoral artery disease. Paclitaxel-eluting drug-coated balloons are emerging as a promising therapy.
Local drug delivery is rapidly...
05/05/2017
Vascular Disease Management
Preliminary Results From the DRASTICO Trial: A Discussion With Francesco Liistro, MD
02/09/2017
An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.
An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.
An interview with the principal...
02/09/2017
Vascular Disease Management
Interview
Preliminary Results From the DRASTICO Trial: A Discussion With Francesco Liistro, MD
02/09/2017
An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.
An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.
An interview with the principal...
02/09/2017
Vascular Disease Management
Interview
Peter Schneider, MD, Shares 1-Year Results From the IN.PACT SFA I and II Trials
03/27/2015
Peter Schneider, MD, describes results from the European and US arms of the IN.PACT SFA trial, which evaluated safety and efficacy of the In.Pact Admiral drug-eluting balloon compared to plain balloon angioplasty in the superficial femoral...
Peter Schneider, MD, describes results from the European and US arms of the IN.PACT SFA trial, which evaluated safety and efficacy of the In.Pact Admiral drug-eluting balloon compared to plain balloon angioplasty in the superficial femoral...
Peter Schneider, MD, describes...
03/27/2015
Vascular Disease Management
Interview
Thomas Zeller, MD, Discusses Failure of DEB to Show Benefit in IN.PACT DEEP
03/27/2015
The multicenter randomized controlled IN.PACT DEEP trial compared paclitaxel-coated balloons with uncoated balloons and failed to show benefit for the drug-eluting balloon.
The multicenter randomized controlled IN.PACT DEEP trial compared paclitaxel-coated balloons with uncoated balloons and failed to show benefit for the drug-eluting balloon.
The multicenter randomized...
03/27/2015
Vascular Disease Management
Interview
Andrej Schmidt, MD, Describes Benefits of Drug-Eluting Balloons for Infrapopliteal Lesions
03/03/2015
Dr. Andrej Schmidt, MD, senior interventionalist at the University Clinic of Leipzig in Germany, discusses results from a single-center study using paclitaxel-coated drug-eluting balloons for infrapopliteal lesions. 
Dr. Andrej Schmidt, MD, senior interventionalist at the University Clinic of Leipzig in Germany, discusses results from a single-center study using paclitaxel-coated drug-eluting balloons for infrapopliteal lesions. 
Dr. Andrej Schmidt, MD, senior...
03/03/2015
Vascular Disease Management
Early Clinical Results for Drug-Eluting Balloons
03/03/2015
Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.
Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.
Drug-eluting balloon therapy is...
03/03/2015
Vascular Disease Management
Clinical Editor's Corner
Early Clinical Results for Drug-Eluting Balloons
03/03/2015
Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.
Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.
Drug-eluting balloon therapy is...
03/03/2015
Vascular Disease Management
Interview
Erik E. Debing, MD, PhD, Discusses the IN.PACT Belgian Diabetic Drug-Coated Balloon Trial
01/26/2015
At the 41st annual VEITHSymposium, Erik E. Debing, MD, PhD, presented mid-term results from the Belgian IN.PACT trial. Vascular Disease Management asked Dr. Debing to share details about the results.
At the 41st annual VEITHSymposium, Erik E. Debing, MD, PhD, presented mid-term results from the Belgian IN.PACT trial. Vascular Disease Management asked Dr. Debing to share details about the results.
At the 41st annual...
01/26/2015
Vascular Disease Management
Gunnar Tepe, MD, Discusses the BIOLUX P-III Study
01/01/2015
Vascular Disease Management spoke about the BIOLUX P-III study with clinical investigator Gunnar Tepe, MD, head of the Institute of Diagnostic and Interventional Radiology at RoMed Clinic Rosenheim in Germany. 
Vascular Disease Management spoke about the BIOLUX P-III study with clinical investigator Gunnar Tepe, MD, head of the Institute of Diagnostic and Interventional Radiology at RoMed Clinic Rosenheim in Germany. 
Vascular Disease Management...
01/01/2015
Vascular Disease Management

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
SAWC Spring
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use